BioWorld 24 nov. 2025 Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld 24 nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld 24 nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III
Roche Media 18 nov. 2025 Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 11 nov. 2025 Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 3 nov. 2025 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial